In contrast, when we added miR-181a inhibitor to PANC-1 and BxPC-3 cells with transfected si-ANRIL, the number of pancreatic cancer cells was higher than that of the si-ANRIL group (Figure 2B). This evidence concerns the gene CDKN2B-AS1 and familial pancreatic carcinoma.